What is the current Angiography Injectors market size?

The current Angiography Injectors market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Angiography Injectors market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Angiography Injectors market?

Key drivers include rising cardiovascular disease prevalence and advancements in medical technology.

What challenges does the Angiography Injectors market face?

Challenges include high equipment costs and stringent regulatory requirements.

Which regions are leading the Angiography Injectors market?

North America and Europe are leading the market due to high healthcare expenditure.

Who are the top companies in the Angiography Injectors market?

Top companies include Medtronics, Siemens, and GE Healthcare, offering innovative solutions.

What future opportunities exist in the Angiography Injectors market?

Future opportunities include emerging markets and technological advancements in injector systems.

How is technology impacting the Angiography Injectors market future outlook?

Technology is driving growth with advancements in injector systems and imaging technologies.

What is the current regulatory landscape for Angiography Injectors?

The regulatory landscape is governed by FDA and CE markings, ensuring safety and efficacy.

Angiography Injectors - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Angiography Injectors by Application (Central Nervous System Disease, Cardiac Macrovascular Disease, Peripheral Vascular Disease), by Types (Single-head Angiography Injectors, Dual-head Angiography Injectors), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1564.1 million

CAGR: 4%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1564.1 million

CAGR: 4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Angiography Injectors Market Overview

The Angiography Injectors market refers to the industry that produces and distributes medical devices used to inject contrast agents into the body during angiography procedures. As a critical component of medical imaging, the Angiography Injectors market size is expected to experience significant growth, driven by an increasing demand for minimally invasive procedures and advancements in medical technology. The growth outlook for the Angiography Injectors market is positive, with a market forecast that indicates a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033, driven by industry expansion and the rising prevalence of cardiovascular diseases. The scope of the market includes angiography equipment, contrast media, and injector systems, with key applications in cardiology, oncology, and neurology.

Loading chart…

The current Angiography Injectors market size is estimated to be approximately $1.4 billion. The growth forecast is driven by macro drivers such as the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the rising demand for minimally invasive procedures. Key forces shaping the industry include technology shifts towards syringeless injectors, regulations regarding contrast media, and consumer behavior towards personalized medicine. The largest region in the Angiography Injectors market is North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by competitive intensity and supply-chain dynamics. As the market continues to evolve, industry players must navigate these key forces to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.56 billion
Revenue forecast in 2033	2.73 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Bayer AG (Medrad Inc.); Bracco Imaging; Guerbet Group; Ulrich; Nemoto Kyorindo; Sino Medical-Device Technology; Apollo RT; Vivid Imaging; Angiodynamics (Navilyst Medical and Segments)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Angiography Injectors market is poised for significant growth, driven by factors such as increasing demand for minimally invasive procedures and advancements in medical technology. The growth forecast for the Angiography Injectors market size is expected to be substantial, with the market expanding at a considerable rate over the next few years.

Growth Drivers2 items

Advances in imaging technologies, such as computed tomography and magnetic resonance imaging, are driving the adoption of Angiography Injectors, leading to increased demand and subsequent growth in the Angiography Injectors market size

The rising prevalence of cardiovascular diseases is fueling the need for diagnostic imaging procedures, thereby contributing to the growth forecast of the Angiography Injectors market

Restraints2 items

Stringent regulatory requirements and high development costs are hindering the growth of the Angiography Injectors market, as companies must invest heavily in research and development to ensure compliance

The Angiography Injectors market is also facing challenges due to competition from alternative diagnostic imaging modalities, which can impact market share and revenue

Opportunities2 items

Emerging economies present significant opportunities for growth in the Angiography Injectors market, driven by increasing healthcare expenditure and a rising demand for advanced medical technologies

The integration of artificial intelligence and machine learning in Angiography Injectors is expected to enhance their functionality and accuracy, thereby driving growth and increasing the Angiography Injectors market size

Challenges2 items

The growth forecast of the Angiography Injectors market is susceptible to fluctuations in the global economy, which can impact healthcare spending and subsequently affect market growth

Ensuring patient safety and preventing contrast agent-related complications are significant challenges faced by the Angiography Injectors market, requiring ongoing innovation and improvement in product design

Market Segmentation

Loading chart…

The Application segment of the Angiography Injectors market refers to the various medical specialties where these devices are utilized. This includes cardiology, oncology, and neurology, among others. The application segment is a crucial aspect of the Angiography Injectors segmentation, as it determines the specific requirements and preferences of different medical fields. For instance, cardiology applications may require higher injection pressures, while oncology applications may necessitate more precise flow rates.

The Types segment of the Angiography Injectors market encompasses various subtypes, including dual-head injectors, single-head injectors, and syringeless injectors. Each subtype has its unique characteristics, advantages, and limitations, contributing to the overall market taxonomy. Understanding these subtypes is essential for manufacturers to develop targeted products and for healthcare providers to select the most suitable devices for their specific needs. The Angiography Injectors market size is significantly influenced by the types segment, as different subtypes cater to distinct application areas and user preferences.

Angiography Injectors Segmentation Breakdown7 items

Application

Central Nervous System Disease

Cardiac Macrovascular Disease

Peripheral Vascular Disease

Types

Single-head Angiography Injectors

Dual-head Angiography Injectors

Regional Insights

Loading chart…

The Angiography Injectors market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of angiography injectors in countries such as China and India.

Key drivers for the North America region include favorable policies, significant investments in healthcare infrastructure, and a mature ecosystem. In Europe, drivers include a high demographics of aging population, increasing infrastructure development, and favorable policies. Asia Pacific's growth is driven by increasing adoption, rising investments in healthcare, and growing infrastructure. Latin America's growth is driven by improving ecosystem maturity, increasing demographics, and growing investments. Middle East & Africa's growth is driven by increasing adoption, rising investments, and improving infrastructure.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by increasing demand for angiography injectors. North America and Europe will continue to dominate the market, while Latin America and Middle East & Africa will experience steady growth. The Angiography Injectors market is expected to grow significantly, driven by increasing adoption and investments in healthcare infrastructure.

Competitive Landscape

The Angiography Injectors market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Angiography Injectors competitive landscape is driven by the need for companies to differentiate themselves through innovative products and services. Global players such as GE Healthcare and Bayer AG (Medrad Inc.) have a significant presence, while local companies focus on regional expansion and customization.

Companies in the Angiography Injectors market employ various strategies to stay competitive, including M&A, partnerships, product launches, and R&D investments. They also focus on differentiation through technology, service models, and channel strength. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay ahead, companies must develop unique value propositions and strategic partnerships.

GE Healthcare: regional expansion

Bayer AG: premium pricing

Bracco Imaging: innovation pipeline

Guerbet Group: local manufacturing

Ulrich: OEM tie-ups

Nemoto Kyorindo: vertical integration

Key Angiography Injectors Companies10 items

GE Healthcare

Bayer AG (Medrad Inc.)

Bracco Imaging

Guerbet Group

Ulrich

Nemoto Kyorindo

Sino Medical-Device Technology

Apollo RT

Vivid Imaging

Angiodynamics (Navilyst Medical and Segments)

Market Ecosystem

The Angiography Injectors ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of angiography injectors, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The ecosystem boundaries are defined by the interactions between these segments, ultimately impacting the delivery of angiography services to patients.

Raw material/component suppliers — providing injector components

OEMs / manufacturers — designing and producing angiography injectors

System integrators / EPCs — integrating injectors into angiography systems

Distributors / channel partners — supplying injectors to healthcare facilities

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing angiography injectors for medical procedures

Regulators/standards bodies — establishing guidelines and standards for injectors

In the Angiography Injectors ecosystem, control points are primarily held by regulatory bodies and end users, as they influence adoption and drive demand. Dependency risks arise from input constraints, such as component availability, and standards approvals, which can impact the production and distribution of injectors. Furthermore, switching costs and interoperability requirements can affect the partnerships between ecosystem participants. A thorough value chain analysis is necessary to understand these dynamics and identify potential bottlenecks, which can vary by region due to differences in healthcare infrastructure and regulatory environments.

Recent Industry Insights

The Angiography Injectors industry has witnessed significant developments over the last 12-18 months, shaping the future of Angiography Injectors industry trends. Recent partnerships between leading medical technology companies have focused on enhancing product portfolios and expanding global reach. Notable mergers and acquisitions have also been observed, with major players consolidating their positions in the market. Furthermore, innovative product launches and technological advancements have improved the efficiency and safety of angiography procedures.

In addition to these developments, regulatory changes have been implemented to ensure stricter safety standards and better patient outcomes. A shift in consumer preferences towards minimally invasive procedures has also driven the demand for advanced angiography injectors. Funding rounds and expansions have enabled companies to invest in research and development, paving the way for future innovations in the Angiography Injectors industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Angiography Injectors market outlook. The market exhibits moderate attractiveness due to increasing demand for minimally invasive procedures and advancements in medical technology. The competitive intensity is high, with key players investing heavily in research and development to improve product offerings. The long-term outlook appears positive, driven by growing demand for angiography procedures and the adoption of innovative technologies.

The innovation landscape is evolving rapidly, with a focus on developing more efficient and patient-friendly systems. The demand-supply balance is stable, with manufacturers working to meet the growing demand for angiography injectors. However, key risk factors include regulatory challenges and intense competition, which may impact market growth. Overall, the Angiography Injectors market outlook is promising, with opportunities for growth and innovation in the coming years.

12 items

1. Executive Summary

2. Angiography Injectors Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Angiography Injectors Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Angiography Injectors Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Angiography Injectors Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Angiography Injectors Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Angiography Injectors Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Angiography Injectors Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Angiography Injectors Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Angiography Injectors Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Angiography Injectors Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Angiography Injectors Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Angiography Injectors Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Angiography Injectors Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Angiography Injectors Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Angiography Injectors Market Competition by Key Manufacturers

9.1. Global Angiography Injectors Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Angiography Injectors: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GE Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bayer AG (Medrad Inc.)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bracco Imaging

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Guerbet Group

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Ulrich

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Nemoto Kyorindo

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Sino Medical-Device Technology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Apollo RT

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Vivid Imaging

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Angiodynamics (Navilyst Medical and Segments)

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Angiography Injectors Market

Figure 4: Global Angiography Injectors Market: Drivers

Figure 5: Global Angiography Injectors Market: Challenges

Figure 6: Global Angiography Injectors Market: Trends

Figure 7: Global Angiography Injectors Market: Opportunity

Figure 8: Global Angiography Injectors Market: Restraint

Figure 9: Global Angiography Injectors Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Angiography Injectors Market Value (USD Million) By Region

Figure 19: Global Angiography Injectors Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Angiography Injectors Market Value (USD Million) By Region

Figure 27: Global Angiography Injectors Market Share (%) By: Regions (2032)

Figure 28: Global Angiography Injectors Market Volume (K) By Region

Figure 29: Global Angiography Injectors Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Angiography Injectors Market Value (USD Million) By Region

Figure 37: Global Angiography Injectors Market Share (%) By: Regions (2032)

Figure 38: Global Angiography Injectors Market Volume (K) By Region

Figure 39: Global Angiography Injectors Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Angiography Injectors Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Angiography Injectors Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Angiography Injectors Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Angiography Injectors Market Value (USD Million) By Region

Table 14: Global Angiography Injectors Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Angiography Injectors Market Volume (K) By Region

Table 31: Global Angiography Injectors Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Angiography Injectors Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Angiography Injectors Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Angiography Injectors Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GE Healthcare Basic Information And Sales Area

Table 52: GE Healthcare. Products Portfolio

Table 53: Bayer AG (Medrad Inc.) Basic Information And Sales Area

Table 54: Bayer AG (Medrad Inc.). Products Portfolio

Table 55: Bracco Imaging Basic Information And Sales Area

Table 56: Bracco Imaging. Products Portfolio

Table 57: Guerbet Group Basic Information And Sales Area

Table 58: Guerbet Group. Products Portfolio

Table 59: Ulrich Basic Information And Sales Area

Table 60: Ulrich. Products Portfolio

Table 61: Nemoto Kyorindo Basic Information And Sales Area

Table 62: Nemoto Kyorindo. Products Portfolio

Table 63: Sino Medical-Device Technology Basic Information And Sales Area

Table 64: Sino Medical-Device Technology. Products Portfolio

Table 65: Apollo RT Basic Information And Sales Area

Table 66: Apollo RT. Products Portfolio

Table 67: Vivid Imaging Basic Information And Sales Area

Table 68: Vivid Imaging. Products Portfolio

Table 69: Angiodynamics (Navilyst Medical and Segments) Basic Information And Sales Area

Table 70: Angiodynamics (Navilyst Medical and Segments). Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Angiography Injectors Market Value (USD Million) By Region

Table 80: Global Angiography Injectors Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Angiography Injectors Market Volume (K) By Region

Table 97: Global Angiography Injectors Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Angiography Injectors Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.56 billion
Revenue forecast in 2033	2.73 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Bayer AG (Medrad Inc.); Bracco Imaging; Guerbet Group; Ulrich; Nemoto Kyorindo; Sino Medical-Device Technology; Apollo RT; Vivid Imaging; Angiodynamics (Navilyst Medical and Segments)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising prevalence of cardiovascular diseases is fueling the need for diagnostic imaging procedures, thereby contributing to the growth forecast of the Angiography Injectors market

Restraints2 items

The Angiography Injectors market is also facing challenges due to competition from alternative diagnostic imaging modalities, which can impact market share and revenue

Opportunities2 items

Emerging economies present significant opportunities for growth in the Angiography Injectors market, driven by increasing healthcare expenditure and a rising demand for advanced medical technologies

Challenges2 items

The growth forecast of the Angiography Injectors market is susceptible to fluctuations in the global economy, which can impact healthcare spending and subsequently affect market growth

Market Segmentation

Loading chart…

Angiography Injectors Segmentation Breakdown7 items

Application

Central Nervous System Disease

Cardiac Macrovascular Disease

Peripheral Vascular Disease

Types

Single-head Angiography Injectors

Dual-head Angiography Injectors

Regional Insights

Loading chart…

Competitive Landscape

GE Healthcare: regional expansion

Bayer AG: premium pricing

Bracco Imaging: innovation pipeline

Guerbet Group: local manufacturing

Ulrich: OEM tie-ups

Nemoto Kyorindo: vertical integration

Key Angiography Injectors Companies10 items

GE Healthcare

Bayer AG (Medrad Inc.)

Bracco Imaging

Guerbet Group

Ulrich

Nemoto Kyorindo

Sino Medical-Device Technology

Apollo RT

Vivid Imaging

Angiodynamics (Navilyst Medical and Segments)

Market Ecosystem

Raw material/component suppliers — providing injector components

OEMs / manufacturers — designing and producing angiography injectors

System integrators / EPCs — integrating injectors into angiography systems

Distributors / channel partners — supplying injectors to healthcare facilities

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing angiography injectors for medical procedures

Regulators/standards bodies — establishing guidelines and standards for injectors

Recent Industry Insights

Analyst Overview

Table of Contents